FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1501833360> ?p ?o ?g. }

• W1501833360 endingPage "266" @default.
• W1501833360 startingPage "254" @default.
• W1501833360 abstract "Nitric oxide (NO), a small effector molecule produced enzymatically from L-arginine by nitric oxide synthase (NOS), is a mediator not only of important homeostatic mechanisms (e.g., blood vessel tone and tissue perfusion), but also of key aspects of local and systemic inflammatory responses. Previous efforts to develop inhibitors of NOS to protect against NO-mediated tissue damage in endotoxin shock have been unsuccessful, largely because such competitive NOS antagonists interfere with critical vasoregulatory NO production in blood vessels and decrease survival in endotoxemic animals. Accordingly, we sought to develop a pharmaceutical approach to selectively inhibit NO production in macrophages while sparing NO responses in blood vessels. The processes of cytokine-inducible L-arginine transport and NO production were studied in the murine macrophage-like cell line (RAW 264.7). A series of multivalent guanylhydrazones were synthesized to inhibit cytokine-inducible L-arginine transport. One such compound (CNI-1493) was studied further in animal models of endothelial-derived relaxing factor (EDRF) activity, carrageenan inflammation, and lethal lipopolysaccharide (LPS) challenge. Upon activation with cytokines, macrophages increase transport of L-arginine to support the production of NO by NOS. Since endothelial cells do not require this additional arginine transport to produce NO, we reasoned that a competitive inhibitor of cytokine-inducible L-arginine transport would not inhibit EDRF activity in blood vessels, and thus might be effectively employed against endotoxic shock. CNI-1493, a tetravalent guanylhydrazone, proved to be a selective inhibitor of cytokine-inducible arginine transport and NO production, but did not inhibit EDRF activity. In mice, CNI-1493 prevented the development of carrageenan-induced footpad inflammation, and conferred protection against lethal LPS challenge. A selective inhibitor of cytokine-inducible L-arginine transport that does not inhibit vascular EDRF responses is effective against endotoxin lethality and significantly reduces inflammatory responses." @default.
• W1501833360 created "2016-06-24" @default.
• W1501833360 creator A5002416515 @default.
• W1501833360 creator A5020928977 @default.
• W1501833360 creator A5036625600 @default.
• W1501833360 creator A5043138301 @default.
• W1501833360 creator A5048757462 @default.
• W1501833360 creator A5051344609 @default.
• W1501833360 creator A5068425146 @default.
• W1501833360 creator A5069190201 @default.
• W1501833360 creator A5070897143 @default.
• W1501833360 creator A5070954728 @default.
• W1501833360 date "1995-03-01" @default.
• W1501833360 modified "2023-10-15" @default.
• W1501833360 title "An Inhibitor of Macrophage Arginine Transport and Nitric Oxide Production (CNI-1493) Prevents Acute Inflammation and Endotoxin Lethality" @default.
• W1501833360 cites W1025584546 @default.
• W1501833360 cites W116883651 @default.
• W1501833360 cites W1212704 @default.
• W1501833360 cites W1540820582 @default.
• W1501833360 cites W1558486290 @default.
• W1501833360 cites W1575097947 @default.
• W1501833360 cites W1611751935 @default.
• W1501833360 cites W1613263812 @default.
• W1501833360 cites W1761071577 @default.
• W1501833360 cites W1834041853 @default.
• W1501833360 cites W1968540078 @default.
• W1501833360 cites W1968713831 @default.
• W1501833360 cites W1996594757 @default.
• W1501833360 cites W2002787536 @default.
• W1501833360 cites W2003458150 @default.
• W1501833360 cites W2004343006 @default.
• W1501833360 cites W2004475073 @default.
• W1501833360 cites W2009013636 @default.
• W1501833360 cites W2010707246 @default.
• W1501833360 cites W2038434279 @default.
• W1501833360 cites W2040179836 @default.
• W1501833360 cites W2040619561 @default.
• W1501833360 cites W2041358315 @default.
• W1501833360 cites W2054345018 @default.
• W1501833360 cites W2057025197 @default.
• W1501833360 cites W2062824264 @default.
• W1501833360 cites W2067681349 @default.
• W1501833360 cites W2070069178 @default.
• W1501833360 cites W2075538547 @default.
• W1501833360 cites W2086158730 @default.
• W1501833360 cites W2092763906 @default.
• W1501833360 cites W2114298357 @default.
• W1501833360 cites W2116660695 @default.
• W1501833360 cites W2117752645 @default.
• W1501833360 cites W2120005533 @default.
• W1501833360 cites W2141493942 @default.
• W1501833360 cites W2156275638 @default.
• W1501833360 cites W2160302014 @default.
• W1501833360 cites W2161769916 @default.
• W1501833360 cites W2171561094 @default.
• W1501833360 cites W2179702494 @default.
• W1501833360 cites W2187771220 @default.
• W1501833360 cites W2313326603 @default.
• W1501833360 cites W2335986199 @default.
• W1501833360 cites W2394606541 @default.
• W1501833360 cites W2413606217 @default.
• W1501833360 cites W2462509345 @default.
• W1501833360 cites W4290213215 @default.
• W1501833360 doi "https://doi.org/10.1007/bf03401550" @default.
• W1501833360 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2229913" @default.
• W1501833360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8529104" @default.
• W1501833360 hasPublicationYear "1995" @default.
• W1501833360 type Work @default.
• W1501833360 sameAs 1501833360 @default.
• W1501833360 citedByCount "111" @default.
• W1501833360 countsByYear W15018333602012 @default.
• W1501833360 countsByYear W15018333602013 @default.
• W1501833360 countsByYear W15018333602014 @default.
• W1501833360 countsByYear W15018333602015 @default.
• W1501833360 countsByYear W15018333602016 @default.
• W1501833360 countsByYear W15018333602018 @default.
• W1501833360 countsByYear W15018333602021 @default.
• W1501833360 countsByYear W15018333602022 @default.
• W1501833360 crossrefType "journal-article" @default.
• W1501833360 hasAuthorship W1501833360A5002416515 @default.
• W1501833360 hasAuthorship W1501833360A5020928977 @default.
• W1501833360 hasAuthorship W1501833360A5036625600 @default.
• W1501833360 hasAuthorship W1501833360A5043138301 @default.
• W1501833360 hasAuthorship W1501833360A5048757462 @default.
• W1501833360 hasAuthorship W1501833360A5051344609 @default.
• W1501833360 hasAuthorship W1501833360A5068425146 @default.
• W1501833360 hasAuthorship W1501833360A5069190201 @default.
• W1501833360 hasAuthorship W1501833360A5070897143 @default.
• W1501833360 hasAuthorship W1501833360A5070954728 @default.
• W1501833360 hasBestOaLocation W15018333601 @default.
• W1501833360 hasConcept C134018914 @default.
• W1501833360 hasConcept C178790620 @default.
• W1501833360 hasConcept C185592680 @default.
• W1501833360 hasConcept C202751555 @default.
• W1501833360 hasConcept C203014093 @default.
• W1501833360 hasConcept C2776914184 @default.
• W1501833360 hasConcept C2776992346 @default.
• W1501833360 hasConcept C2777468819 @default.

• next